Navigation Links
'Clinical Endocrinology of Companion Animals'
Date:1/7/2013

Wiley is pleased to announce the publication of a complete, accessible reference for clinically relevant information on managing veterinary patients with endocrine disease.

Clinical Endocrinology of Companion Animals, offers fast access to clinically relevant information on managing the patient with endocrine disease. Written by leading experts in veterinary endocrinology, each chapter takes the same structure to aid in the rapid retrieval of information, offering information on pathogenesis, signalment, clinical signs, diagnosis, differential diagnosis, treatment, prognosis, and prevention for a broad list of endocrine disorders.

With complete coverage of the most common endocrine diseases, the book includes chapters on conditions in dogs, cats, horses, ferrets, reptiles, and other species. Clinical Endocrinology of Companion Animals is a highly practical resource for any veterinarian treating these common diseases.

To speak to the editors or for a review copy of Clinical Endocrinology of Companion Animals, please contact: Michelle Martella at Wiley
Tel: +1 201-748-6145 email: mmartella@wiley.com

Clinical Endocrinology of Companion Animals
January 2013 536pp
978-0-8138-0583-2 Electronic Editions Available
$99.99; CAN $109.99; 75.60; 62.99


'/>"/>

Contact: Michelle Martella
201-748-6145
Wiley
Source:Eurekalert

Page: 1

Related biology news :

1. 3 new research units, 1 new clinical research unit
2. New clinical trial explores use of smartphone application for postpartum weight loss
3. Clinical trial tests rice bran to prevent cancer
4. Greenphire CEO Sam Whitaker speaks on Sunshine Act and Clinical Trial Payments
5. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
6. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
7. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
8. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
9. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
10. BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
11. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion ... Continue Reading ... ... part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The ...
(Date:11/24/2016)... 23, 2016 Cercacor today introduced Ember TM ... trainers non-invasively measure hemoglobin, Oxygen Content, Oxygen ... Respiration Rate in approximately 30 seconds. Smaller than a ... immediate access to key data about their bodies to ... regimen. Hemoglobin carries oxygen to muscles. ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... ... platforms, announced today that the company has engaged in a collaborative research partnership ... (MRDA) with the CSU Office of the Vice President for Research. This agreement ...
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
(Date:12/5/2016)... 2016  Renova™ Therapeutics, a biotechnology company developing ... other chronic diseases, announced that Catherine Bovenizer ... Financial Officer (CFO), effective today. Ms. ... experience in financial management for a variety of ... Most recently, Ms. Bovenizer was the Vice President ...
Breaking Biology Technology: